Literature DB >> 32815984

Association of Industry Sponsorship With Cancer Clinical Trial Accrual.

Dario Pasalic1, Chad Tang1, Reshma Jagsi2, C David Fuller1, Albert C Koong1, Ethan B Ludmir1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32815984      PMCID： PMC7441463          DOI： 10.1001/jamaoncol.2020.1284

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  6 in total

1.  Medical innovation and institutional interdependence: rethinking university-industry connections.

Authors:  Annetine C Gelijns; Samuel O Thier
Journal:  JAMA       Date:  2002-01-02       Impact factor: 56.272

2.  MSJAMA: Industry funding of clinical trials: benefit or bias?

Authors:  Sameer S Chopra
Journal:  JAMA       Date:  2003-07-02       Impact factor: 56.272

3.  Predicting Low Accrual in the National Cancer Institute's Cooperative Group Clinical Trials.

Authors:  Caroline S Bennette; Scott D Ramsey; Cara L McDermott; Josh J Carlson; Anirban Basu; David L Veenstra
Journal:  J Natl Cancer Inst       Date:  2015-12-29       Impact factor: 13.506

4.  Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial Improvement.

Authors:  Chad Tang; Steven I Sherman; Mellanie Price; Jun Weng; Suzanne E Davis; David S Hong; James C Yao; Aman Buzdar; George Wilding; J Jack Lee
Journal:  Clin Cancer Res       Date:  2017-03-08       Impact factor: 12.531

5.  Evolution of the randomized controlled trial in oncology over three decades.

Authors:  Christopher M Booth; David W Cescon; Lisa Wang; Ian F Tannock; Monika K Krzyzanowska
Journal:  J Clin Oncol       Date:  2008-10-27       Impact factor: 44.544

6.  Adult cancer clinical trials that fail to complete: an epidemic?

Authors:  Kristian D Stensland; Russell B McBride; Asma Latif; Juan Wisnivesky; Ryan Hendricks; Nitin Roper; Paolo Boffetta; Simon J Hall; William K Oh; Matthew D Galsky
Journal:  J Natl Cancer Inst       Date:  2014-09-04       Impact factor: 13.506
  6 in total
  3 in total

1.  Prostate cancer clinical trial completion: The role of geography.

Authors:  Kristian D Stensland; Samuel D Kaffenberger; Arvin K George; Todd M Morgan; David C Miller; Simpa S Salami; Rodney L Dunn; Ganesh S Palapattu; Jeffrey S Montgomery; Brent K Hollenbeck; Ted A Skolarus
Journal:  Contemp Clin Trials       Date:  2021-10-19       Impact factor: 2.226

2.  Publication Bias in Gastrointestinal Oncology Trials Performed over the Past Decade.

Authors:  Gabrielle W Peters; Weiwei Tao; Wei Wei; Joseph A Miccio; Krishan R Jethwa; Michael Cecchini; Kimberly L Johung
Journal:  Oncologist       Date:  2021-03-31

3.  Food and Drug Administration approvals in phase 3 Cancer clinical trials.

Authors:  Joseph Abi Jaoude; Ramez Kouzy; Ethan B Ludmir; Cullen M Taniguchi; Marc Ghabach; Roshal Patel; Dario Pasalic; Elie Ghossain; Austin B Miller; Timothy A Lin; Vivek Verma; C David Fuller; Vivek Subbiah; Bruce D Minsky
Journal:  BMC Cancer       Date:  2021-06-12       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.